P-Glycoprotein Expression in Mouse Brain Increases with Maturation

@article{Tsai2002PGlycoproteinEI,
  title={P-Glycoprotein Expression in Mouse Brain Increases with Maturation},
  author={Catherine E. Tsai and Monica J. Daood and Robert H. Lane and Thor Willy Ruud Hansen and Elisa M. Gruetzmacher and Jon F Watchko},
  journal={Neonatology},
  year={2002},
  volume={81},
  pages={58 - 64}
}
The mdr1a isoform of P-glycoprotein (Pgp) is an integral plasma membrane efflux pump expressed in adult brain capillary endothelial cells and astrocytes of the blood-brain barrier. We determined the developmental pattern of Pgp expression in brain tissue at embryonic day 16 (E16), day of life 0 (D0), day of life 7 (D7), day of life 21 (D21), and adults (Ad). The relative expression of Pgp mRNA and protein was indexed as a percent (mean ± SEM) of D0 levels. Pgp mRNA levels increased… 
Expression of P-gp in Glioblastoma: What we can Learn from Brain Development.
TLDR
The analysis of P- gp immunolocalization during brain development may contribute to identify the multiple cellular sources in the GBM vessels that may be involved in P-gp-mediated chemoresistance and can be responsible for GBM therapy failure and tumor recurrence.
P-glycoprotein in the developing human blood–brain barrier
  • J. Watchko
  • Biology, Medicine
    Pediatric Research
  • 2016
TLDR
The developmental increase of human microvascular endothelial cell P- gp/ABCB1 immunostaining mirrors that of murine studies showing marked perinatal, early postnatal, and late postnatal increases in central nervous system microvessel P-gp expression and suggests that murine models may be helpful in studying the developmental effects of P-GP expression oncentral nervous system morphine pharmacodynamics.
Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by Bilirubin at the Blood-CSF and Blood-Brain Barriers in the Gunn Rat
TLDR
The data suggest that down-regulation of Mrp1 protein at the BSCFB, resulting from a direct effect of UCB on epithelial cells, may impact theMrp1-mediated neuroprotective functions of the blood-cerebrospinal fluid barrier and actually potentiate UCB neurotoxicity.
Fetal Blood-Brain Barrier P-Glycoprotein Contributes to Brain Protection During Human Development
TLDR
It is demonstrated that P-gp is expressed early during human cerebral cortical microvessel development, and suggested that at midgestation there may be efflux activity that is regulated by interactions with the caveolar endothelial cell compartment.
Developmental patterns in human blood–brain barrier and blood–cerebrospinal fluid barrier ABC drug transporter expression
TLDR
Human BBB and BCSFB ABC membrane transporters show brain location and transporter-specific maturation, and age-related variation in membrane transporators may impact brain disposition.
Differential expression of the multidrug resistance‐related proteins ABCb1 and ABCc1 between blood‐brain interfaces
TLDR
There are major differences in the mechanisms by which blood‐brain interfaces fulfill their neuroprotective functions, and the data highlight the significance of the neuroProtective function of the choroid plexus during brain maturation, when the microvasculature is still developing.
BRAIN CYCLOSPORIN A LEVELS ARE DETERMINED BY ONTOGENIC REGULATION OF MDR1A EXPRESSION
TLDR
It is concluded that the risk for central nervous system drug toxicity could be higher in neonates or young children as a consequence of underdeveloped P-glycoprotein.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 26 REFERENCES
Developmental expression of P-glycoprotein (multidrug resistance gene product) in the rat brain.
TLDR
Examination of expression and localization of PGP in the rat brain during development indicates that PGP expression increased with postnatal development and is localized in the brain capillaries.
Brain Bilirubin Content Is Increased in P-Glycoprotein-Deficient Transgenic Null Mutant Mice
TLDR
The data suggest that bilirubin is a substrate for P-gp and the increased brain bilirUBin content in mdr1a(-/-) mice is due to enhanced brain bilIRubin influx.
The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood-brain barrier development in the microvessels of the developing human brain
TLDR
Results indicate that Pgp expression in endothelia of brain microvessels occurs regularly in embryos of about 30-mm crown-rump length (CRL), and is therefore an early marker of the blood-brain barrier in the developing human brain.
Isoform I (mdr3) is the major form of P-glycoprotein expressed in mouse brain capillaries. Evidence for cross-reactivity of antibody C219 with an unrelated protein.
TLDR
Results show that a 190 kDa protein detected by antibody C219 is an antigen unrelated to the three P-gp isoforms presently known, and cross-reactivity of C219 with an unrelated protein emphasizes the fact that more than one antibody should be used in the assessment of P- gp expression in cell lines and tissues.
Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.
TLDR
It is shown that the mouse mdr1a and the human MDR1 P-glycoprotein actively transport ivermectin, dexamethasone, digoxin, and cyclosporin A and, to a lesser extent, morphine across a polarized kidney epithelial cell layer in vitro.
Brain Microvascular and Astrocyte Localization of P‐Glycoprotein
TLDR
Evidence is provided that P‐glycoprotein does not play a functional role at the luminal membrane of the brain capillary endothelium in vivo, and that a principal site of immunoreactive P‐ glycoprotein in brain microvasculature is localized to astrocyte foot processes.
Mouse multidrug resistance 1a/3 gene is the earliest known endothelial cell differentiation marker during blood‐brain barrier development
  • Ying Qin, Thomas N. Sato
  • Biology, Medicine
    Developmental dynamics : an official publication of the American Association of Anatomists
  • 1995
TLDR
expression of the mouse multidrug resistance la/3 (mdrla/3) gene can be detected specifically in subsets of vascular endothelial cells associated with neural tissues at as early as embryonic day 10.5, which is the earliest endothelial cell differentiation marker gene during BBB development described thus far.
P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.
TLDR
It is shown here that the drugs loperamide, domperidone, and ondansetron are transported substrates for the mouse mdr1a P-GP and its human homologue MDR1, and the possible role that the drug-transporting P- GP(s) may play in the clinical use of many drugs, especially those with potential targets in the central nervous system.
...
1
2
3
...